Synthesis of Phenyl 2-Acetamidoselenogalactoside Mimetics and Interaction with Amyloid β1–42
Pharmaceuticals · 27.05.2026 · 19 (6) · 836
DOI: 10.3390/ph19060836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 27.05.2026. Verfasst von João Barros und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Ed C8, Piso 5, 1749-016 Lisboa, Portuga…. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Background/Objectives: Protein–carbohydrate interactions are implicated in amyloid aggregation pathways associated with Alzheimer’s disease (AD). Designing glycomimetics that modulate amyloid assembly represents a promising strategy. In addition, the interaction of Aβ1–42 oligomers (Aβo) with prion protein (PrPC) activates Fyn kinase and leads to Tau hyperphosphorylation, another process characterizing AD. Thus, we generated a library of phenyl 2-acetamidoselenogalactoside mimetics to evaluate their interactions with Aβo and disruption of Aβo–PrPC binding, and consequently their potential to inhibit Fyn kinase activation.
Methods
The synthetic approach comprised azidophenylselenylation, a modified one-pot Staudinger reduction–acylation, a selective α-glycosylation, and deacetylation. Structural diversity was achieved mainly via acylation or ureation. The compounds were screened for binding to Aβo using STD-NMR, 19F-NMR, and rapid equilibrium dialysis (RED). ADME properties were assessed through microsomal metabolism and solubility assays, while cytotoxicity was evaluated by MTT assays in human embryonic kidney (HEK) cells.
Results
Several compounds bound Aβo in STD-NMR experiments, mainly through aromatic and anomeric protons, and phenyl 2-deoxy-2-phenylureido-1-seleno-α-d-galactopyranoside (34) showed the most consistent response, with >50% increase in relative binding signal in competition assays, demonstrating also some inhibition of Aβo–PrPC interactions (12%). Selenium at the anomeric position enhanced binding compared to sulphur and oxygen analogs. RED experiments confirmed weak binding interactions, consistent with STD-NMR results. ADME revealed that acetylated compounds undergo microsomal metabolism, whereas deacetylated derivatives displayed high aqueous solubility (>100 μM) and showed no cytotoxicity.
Conclusions
Phenyl 2-acetamidoselenogalactosides are a novel class of amyloid-binding glycomimetics. Among them, 34 emerges as the most promising compound, combining favorable solubility, metabolic stability, low toxicity, and measurable interference with Aβo and Aβo–PrPC interactions, thus supporting further developments toward therapeutic applications in AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Ed C8, Piso 5, 1749-016 Lisboa, Portugal.
- Independent Researcher, Chemin de Joulens, 1, 1110 Morges, Switzerland.
- Independent Researcher, Basingstoke RG25, UK.
- Independent Researcher, Ascot SL5, UK.
- Department of Chemistry, University of Sheffield, Brookhill, Shefield S3 7HF, UK.
- Mass Spectrometry Facility, Centro de Química Estruttural, Instituto Superior Técnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
ORCID-Profile: João Barros, Gonçalo C Justino, Maria C Oliveira, Amélia P Rauter
Förderung
- European Union
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Barros, J., Dreyfus, N., Sharman, G., Evans, D., Chen, B., Souza, C. S., Justino, G. C., Oliveira, M. C., & Rauter, A. P. (2026). Synthesis of Phenyl 2-Acetamidoselenogalactoside Mimetics and Interaction with Amyloid β1–42. Pharmaceuticals, 19(6), 836. https://doi.org/10.3390/ph19060836
Vancouver
Barros J, Dreyfus N, Sharman G, Evans D, Chen B, Souza CS, et al. Synthesis of Phenyl 2-Acetamidoselenogalactoside Mimetics and Interaction with Amyloid β1–42. Pharmaceuticals. 2026;19(6):836. doi:10.3390/ph19060836
BibTeX
@article{Barros2026,
author = {Barros, João and Dreyfus, Nicolas and Sharman, Gary and Evans, David and Chen, Beining and Souza, Cleide S and Justino, Gonçalo C and Oliveira, Maria C and Rauter, Amélia P},
title = {Synthesis of Phenyl 2-Acetamidoselenogalactoside Mimetics and Interaction with Amyloid β1–42},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {6},
pages = {836},
doi = {10.3390/ph19060836}
}
EUVIMED